Records containing: Tuberous Sclerosis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2022-04-25A Phase II Multi-Center Study of Rapamycin for Treating Kidney Angiomyolipomas in TSC or LAM Patients
-
CLINICAL_TRIALS study record update · 2020-11-06Mechanisms of Change With Early Intervention in Tuberous Sclerosis
-
CLINICAL_TRIALS study record update · 2020-10-26Phase II Study of Topical Rapamycin to Erase Angiofibromas in TSC-Multicenter Evaluation of a Novel Therapy
-
CLINICAL_TRIALS study record update · 2019-12-17Studies of Autistic Patients: Gene Networks and Clinical Subtypes
-
CLINICAL_TRIALS study record update · 2019-03-06Effect of Fasting on the Size of Lymphangioleiomyomas in Patients With Lymphangioleiomyomatosis
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2019-02-20A Long-term, Single-arm, Open-label Trial of NPC-12G (Topical Formulation of Sirolimus) to Angiofibroma and Other Skin Lesions in Patients With Tuberous Sclerosis Complex
-
CLINICAL_TRIALS study record update · 2018-04-30Turmeric as Treatment in Epilepsy
-
CLINICAL_TRIALS study record update · 2018-01-30TRON: A Randomised, Double Blind, Placebo-controlled Study of RAD001 (Everolimus) in the Treatment of Neurocognitive Problems in Tuberous Sclerosis
-
CLINICAL_TRIALS study record update · 2018-01-23Treatment of Renal Angiomyolipomas in Tuberous Sclerosis by Beta-blockers: Pilot Trial
-
CLINICAL_TRIALS study record update · 2017-02-02A Double-blind, Randomized, Placebo-controlled Phase III Trial to Investigate the Efficacy and Safety of NPC-12G Gel (Topical Formulation of Sirolimus) to Angiofibroma and Other Skin Lesions in Patients With Tuberous Sclerosis Complex
-
CLINICAL_TRIALS study record update · 2015-12-02A Randomised, Double Blind, Placebo Controlled Trial of Doxycycline in Lymphangioleiomyomatosis.
-
CLINICAL_TRIALS study record update · 2014-10-20Everolimus (RAD001)Therapy of Giant Cell Astrocytomas in Patients With Tuberous Sclerosis Complex
-
CLINICAL_TRIALS study record update · 2013-09-25RAD001 Therapy of Angiomyolipomata in Patients With Tuberous Sclerosis Complex and Sporadic Lymphangioleiomyomatosis
-
CLINICAL_TRIALS study record update · 2013-09-18Long Term Follow Up for RAD001 Therapy of Angiomyolipomata in Patients With Tuberous Sclerosis Complex and Sporadic Lymphangioleiomyomatosis
-
CLINICAL_TRIALS study record update · 2012-05-01A Randomized, Double-blind, Placebo-controlled Study of Everolimus in the Treatment of Patients With Subependymal Giant Cell Astrocytomas (SEGA) Associated With Tuberous Sclerosis Complex (TSC)
-
CLINICAL_TRIALS study record update · 2012-02-27Topical Rapamycin Therapy to Alleviate Cutaneous Manifestations of Tuberous Sclerosis Complex and Neurofibromatosis 1
-
CLINICAL_TRIALS study record update · 2008-04-30A Trial of the Efficacy and Safety of Sirolimus(Rapamycin)Therapy for Renal Angiomyolipmoas in Patients With Tuberous Sclerosis Complex and Sporadic Lymphangioleiomyomatosis
-
CLINICAL_TRIALS study record update · 2007-04-09Rapamycin Therapy of Angiomyolipomas in Patients With Tuberous Sclerosis Complex and Sporadic Lymphangioleiomyomatosis